Fremanezumab effectiveness and tolerability in clinical routine: interim real-world-data of the observational FINESSE study

被引：0
作者：
Straube, A. [1 ]
Broessner, G. [2 ]
Gaul, C. [3 ]
Hamann, X. [4 ]
Kraya, T. [5 ,6 ]
Neeb, L. [7 ,8 ]
机构：
[1] Univ Hosp LMU Munich, Dept Neurol, Munich, Germany
[2] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[3] Headache Ctr Frankfurt, Frankfurt, Germany
[4] Teva GmbH, Ulm, Germany
[5] Hosp Sankt Georg Leipzig gGmbH, Dept Neurol, Headache Ctr Halle, Leipzig, Germany
[6] Univ Hosp Halle, Dept Neurol, Headache Ctr Halle, Halle, Saale, Germany
[7] Helios Global Hlth, Berlin, Germany
[8] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P040
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness & safety of fremanezumab in migraine: 3rd interim analysis of the pan-European PEARL study
    Ashina, M.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Campos, V. Ramirez
    Ning, X.
    Lyras, L.
    Tassorelli, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 149 - 150
  • [22] Real-World effectiveness and safety of fremanezumab in migraine: 3rd interim analysis of the pan-european PEARL study
    Ashina, M.
    Mitsikostas, D. D.
    Amin, F. Mohammad
    Kokturk, P.
    Schankin, C. J.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A. Christine
    Martins, I. Pavao
    Sumelahti, M. L.
    Campos, V. Ramirez
    Ning, X.
    Lyras, L.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [23] The PEARL study protocol: a pan-european prospective observational study of fremanezumab effectiveness in patients with chronic or episodic migraine in the real world
    Ashina, M.
    Amin, F. M.
    Kokturk, P.
    Cohen, J. M.
    Konings, M.
    Tassorelli, C.
    Mitsikostas, D. -D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 607 - 607
  • [24] Methods for Extrapolating Findings from Randomized Clinical Trials using Real-World-Data
    Izem, Rima
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 363 - 364
  • [25] Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study
    Cullum, Christopher Kjaer
    Chaudhry, Basit Ali
    Do, Thien Phu
    Amin, Faisal Mohammad
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [26] REAL-WORLD CLINICAL CHARACTERISTICS OF PATIENTS WITH MIGRAINE WHO INITIATED FREMANEZUMAB IN SWEDEN: AN OBSERVATIONAL, NATIONWIDE REGISTERBASED STUDY
    Linde, M.
    Driessen, M.
    Akcicek, H.
    Blomstrand, F.
    Fast, T.
    Haas, J.
    Krasenbaum, L. J.
    Seidel, K.
    Vasilevska, M.
    Ernstsson, O.
    VALUE IN HEALTH, 2023, 26 (12) : S493 - S493
  • [27] Effectiveness of Tenecteplase versus Alteplase in Acute Ischemic Stroke Selected Subgroups of a Real-World-Data Set
    Silva, Luis
    Khan, Shayan
    Ramezani, Solmaz
    Stalin, Karen
    Annam, Saketh
    Roberts, Rebecca
    Schneck, David
    Streib, Christopher D.
    STROKE, 2024, 55
  • [28] Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
    Mattingly, G.
    Christensen, M.
    Simonsen, K.
    Hammer-Helmich, L.
    Ren, H.
    EUROPEAN PSYCHIATRY, 2021, 64 : S341 - S341
  • [29] Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice
    Amin, Moein
    Harvey, Tucker
    Pineda, Dan Michael
    Tai, Ming-Hui
    Shao, Qiujun
    Brown, Brandon
    Gadkari, Abhijit
    Moss, Brandon
    Conway, Devon S.
    Hersh, Carrie M.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2025, 15 (01) : 27 - 36
  • [30] Real-world Effectiveness and Tolerability of Etrasimod in Active Ulcerative Colitis: A 26-week Observational Study
    St-Pierre, J.
    Choi, D.
    Yanofsky, R.
    Fear, E.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1540 - i1540
12345